PP_1170x120_10-25-21

Lari Harding is vice president of client development at Inmar ­Intelligence.

Pharmacy must reckon with the cost of transparency

Pharmacy must reckon with the cost of transparency

In the business of pharmacy, there is a cost to not having transparency. And there is a cost attached to transparency. The question is which of these is better for you and your customers. It’s an increasingly important question given the growth of health care. The consumer health care industry grew 12% in 2021 while

A new vantage point on population health

A new vantage point on population health

The definition of population health, as we all think about it, refers to the health status and health outcomes within a group of people rather than considering the health of one person at a time. It often includes an emphasis on primary care, it’s data driven, involves physician leadership, and is focused on disease management.

This is the time for community pharmacy’s reinvention

This is the time for community pharmacy’s reinvention

Even before the pandemic, pharmacies were struggling. Now, the pressures are even greater as demand shifts, digital disruption escalates and the need for health equity is in the spotlight. Access to health care is critical for Americans, and 90% of Americans live within five miles of a pharmacy. While there are some components of health

The pandemic is accelerating pharmacy innovation

The pandemic is accelerating pharmacy innovation

Health care needs changes. We have been talking about them for years. We all know what they are — better care, lower costs and more accessibility. I find myself thinking that necessity is the mother of invention — or at least the accelerator of change. COVID-19 has spurred an acceleration of innovation and creativity that